https://stock.noler.com/us/stock/insys-therapeutics-inc https://stock.noler.com/us/stock/insys-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/insys-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/insys-therapeutics-inc/accretion-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/insys-therapeutics-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/insys-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/insys-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/insys-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/insys-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/assets-fair-value-disclosure-nonrecurring https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-five-through-ten-years-amortized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-five-through-ten-years-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-ten-years-amortized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-after-ten-years-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-remainder-of-fiscal-year-amortized-cost-basis https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-remainder-of-fiscal-year-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/available-for-sale-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/insys-therapeutics-inc/buyback-authorization https://stock.noler.com/us/stock/insys-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/insys-therapeutics-inc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/insys-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/insys-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/insys-therapeutics-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/insys-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/insys-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/insys-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/insys-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/insys-therapeutics-inc/concentration-risk-percentage https://stock.noler.com/us/stock/insys-therapeutics-inc/construction-in-progress-gross https://stock.noler.com/us/stock/insys-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/insys-therapeutics-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/insys-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/insys-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/insys-therapeutics-inc/current-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/insys-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/customer-refund-liability-current https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-and-equity-securities-unrealized-gain-loss-excluding-other-than-temporary-impairment https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/insys-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-rent-credit https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/insys-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/insys-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/insys-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/insys-therapeutics-inc/depreciation https://stock.noler.com/us/stock/insys-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/insys-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/insys-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/insys-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/insys-therapeutics-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/insys-therapeutics-inc/eps https://stock.noler.com/us/stock/insys-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/insys-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/insys-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/insys-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/gain-loss-on-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/insys-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/insys-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/insys-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/insys-therapeutics-inc/income-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/insys-therapeutics-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/insys-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/insys-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/insys-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/insys-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/insys-therapeutics-inc/interest-and-debt-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/insys-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/insys-therapeutics-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-gross https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/insys-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/insys-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/insys-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/insys-therapeutics-inc/investment-owned-at-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/investment-owned-at-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/legal-fees https://stock.noler.com/us/stock/insys-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/insys-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/level-3-asset-gain-loss-included-in-earnings https://stock.noler.com/us/stock/insys-therapeutics-inc/level-3-asset-purchases https://stock.noler.com/us/stock/insys-therapeutics-inc/level-3-asset-value https://stock.noler.com/us/stock/insys-therapeutics-inc/liabilities-fair-value-disclosure-nonrecurring https://stock.noler.com/us/stock/insys-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/insys-therapeutics-inc/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/insys-therapeutics-inc/line-of-credit-facility-interest-rate-at-period-end https://stock.noler.com/us/stock/insys-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/insys-therapeutics-inc/lines-of-credit-current https://stock.noler.com/us/stock/insys-therapeutics-inc/litigation-reserve https://stock.noler.com/us/stock/insys-therapeutics-inc/litigation-reserve-current https://stock.noler.com/us/stock/insys-therapeutics-inc/litigation-reserve-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/litigation-settlement-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/insys-therapeutics-inc/net-income https://stock.noler.com/us/stock/insys-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/insys-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/insys-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-change-on-net-income https://stock.noler.com/us/stock/insys-therapeutics-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/insys-therapeutics-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/insys-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-income https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/insys-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/insys-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/insys-therapeutics-inc/other-income https://stock.noler.com/us/stock/insys-therapeutics-inc/other-inventory https://stock.noler.com/us/stock/insys-therapeutics-inc/other-inventory-net-of-reserves https://stock.noler.com/us/stock/insys-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/insys-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/insys-therapeutics-inc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-dividend-rate-per-dollar-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-liquidation-preference https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/insys-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/insys-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/insys-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/insys-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/insys-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/insys-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/insys-therapeutics-inc/property-plant-and-equipment-fair-value-disclosure https://stock.noler.com/us/stock/insys-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/insys-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/insys-therapeutics-inc/public-float https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-after-fifth-year https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-in-fifth-year https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/insys-therapeutics-inc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/insys-therapeutics-inc/realized-investment-gains-losses https://stock.noler.com/us/stock/insys-therapeutics-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/insys-therapeutics-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/insys-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/insys-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/insys-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/insys-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/insys-therapeutics-inc/revenue https://stock.noler.com/us/stock/insys-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/insys-therapeutics-inc/sales-revenue-goods-net-percentage https://stock.noler.com/us/stock/insys-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/insys-therapeutics-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/share-price https://stock.noler.com/us/stock/insys-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/insys-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/insys-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/insys-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/short-term-borrowings https://stock.noler.com/us/stock/insys-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-accelerated-compensation-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/insys-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/insys-therapeutics-inc/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/insys-therapeutics-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/insys-therapeutics-inc/tangible-asset-impairment-charges https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/insys-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/insys-therapeutics-inc/total-assets https://stock.noler.com/us/stock/insys-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/insys-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/insys-therapeutics-inc/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/insys-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/insys-therapeutics-inc/unrealized-loss-on-securities https://stock.noler.com/us/stock/insys-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/insys-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/insys-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/insys-therapeutics-inc/weighted-average-number-of-shares-issued-basic